^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    autologous formalin-fixed tumor vaccine

    i
    Other names: autologous formalin-fixed tumor vaccine, AFTV, AFTVac
    Associations

    News

    Trials
    Company:
    Cell-Medicine
    Drug class:
    Immunostimulant
    Related drugs:
    Associations

    News

    Trials
    over1year
    P53-negative status and gross total resection as predictive factors for autologous tumor vaccine treatment in newly diagnosed glioblastoma patients. (PubMed, Neurooncol Adv)
    A p53-negative status in IHC and GTR were the predictive factors for AFTV treatment in newly diagnosed GBM patients. Microenvironment-targeted treatment and pretreatment blood cell status may be key factors to enhance therapy effects.
    Journal
    |
    autologous formalin-fixed tumor vaccine